These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1327035)
21. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer. Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890 [TBL] [Abstract][Full Text] [Related]
22. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE; Bepler G; Kubasch M; Havemann K Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028 [TBL] [Abstract][Full Text] [Related]
23. Comparison of amplified and unamplified c-myc gene structure and expression in human small cell lung carcinoma cell lines. Seifter EJ; Sausville EA; Battey J Cancer Res; 1986 Apr; 46(4 Pt 2):2050-5. PubMed ID: 3004717 [TBL] [Abstract][Full Text] [Related]
24. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Gazzeri S; Brambilla E; Jacrot M; Chauvin C; Benabid AL; Brambilla C Cancer Res; 1991 May; 51(10):2566-71. PubMed ID: 1850659 [TBL] [Abstract][Full Text] [Related]
25. Coexisting amplifications of the chromosome 1p32 genes (PTPRF and MYCL1) encoding protein tyrosine phosphatase LAR and L-myc in a small cell lung cancer line. Harder KW; Saw J; Miki N; Jirik F Genomics; 1995 Jun; 27(3):552-3. PubMed ID: 7558042 [No Abstract] [Full Text] [Related]
26. Identification of frequent novel genetic alterations in small cell lung carcinoma. Levin NA; Brzoska P; Gupta N; Minna JD; Gray JW; Christman MF Cancer Res; 1994 Oct; 54(19):5086-91. PubMed ID: 7923122 [TBL] [Abstract][Full Text] [Related]
27. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer. Bai L; Sun Y; Li S Chin Med J (Engl); 1997 Apr; 110(4):250-4. PubMed ID: 9594222 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365 [TBL] [Abstract][Full Text] [Related]
29. Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription. Dooley S; Wundrack I; Blin N; Welter C Biochem Biophys Res Commun; 1995 Aug; 213(3):789-95. PubMed ID: 7654239 [TBL] [Abstract][Full Text] [Related]
30. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements. Kumagai T; Tanio Y; Osaki T; Hosoe S; Tachibana I; Ueno K; Kijima T; Horai T; Kishimoto T Cancer Res; 1996 Jan; 56(2):354-8. PubMed ID: 8542591 [TBL] [Abstract][Full Text] [Related]
31. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Shiraishi M; Noguchi M; Shimosato Y; Sekiya T Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414 [TBL] [Abstract][Full Text] [Related]
32. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
33. myc family gene abnormality in lung cancers and its relation to xenotransplantability. Gemma A; Nakajima T; Shiraishi M; Noguchi M; Gotoh M; Sekiya T; Niitani H; Shimosato Y Cancer Res; 1988 Nov; 48(21):6025-8. PubMed ID: 3167852 [TBL] [Abstract][Full Text] [Related]
34. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593 [TBL] [Abstract][Full Text] [Related]
35. A study of myc-related gene expression in small cell lung cancer by in situ hybridization. Gu J; Linnoila RI; Seibel NL; Gazdar AF; Minna JD; Brooks BJ; Hollis GF; Kirsch IR Am J Pathol; 1988 Jul; 132(1):13-7. PubMed ID: 2456019 [TBL] [Abstract][Full Text] [Related]
36. Genome analysis of small cell lung cancer (SCLC) and clinical significance. Buys CH; Osinga J; van der Veen AY; Mooibroek H; van der Hout AH; de Leij L; Postmus PE; Carritt B Eur J Respir Dis Suppl; 1987; 149():29-36. PubMed ID: 3034645 [TBL] [Abstract][Full Text] [Related]
37. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers. Taya Y Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029 [TBL] [Abstract][Full Text] [Related]
38. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. Sekine I; Takami S; Guang SG; Yokose T; Kodama T; Nishiwaki Y; Kinoshita M; Matsumoto H; Ogura T; Nagai K Oncol Rep; 1998; 5(2):351-4. PubMed ID: 9468555 [TBL] [Abstract][Full Text] [Related]
39. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Ibson JM; Rabbitts PH Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684 [TBL] [Abstract][Full Text] [Related]
40. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]